Filing Details
- Accession Number:
- 0001104659-21-050369
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-14 20:24:13
- Reporting Period:
- 2021-04-13
- Accepted Time:
- 2021-04-14 20:24:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356576 | Supernus Pharmaceuticals Inc. | SUPN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1539494 | Tillotson Tami Martin | C/O Supernus Pharmaceuticals, Inc. 9715 Key West Avenue Rockville MD 20850 | Sr. V.p., Regulatory Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-13 | 3,125 | $12.98 | 89,451 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-13 | 3,125 | $29.98 | 86,326 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-14 | 3,125 | $12.98 | 89,451 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-14 | 3,125 | $31.98 | 86,326 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-04-13 | 3,125 | $0.00 | 3,125 | $12.98 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-04-14 | 3,125 | $0.00 | 3,125 | $12.98 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,375 | 2026-03-01 | No | 4 | M | Direct | |
| 6,250 | 2026-03-01 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted March 11, 2021.
- The option vests in four equal annual installments beginning on March 1, 2017.
Billionaire Hedge Funds
